Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-α and IFN-γ

Cytokines and Molecular Therapy

Volumn 2, Issue 3, 1996, Pages 147-160

  Munker, Reinhold ^a   Andreeff, Michael ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

AML; Apoptosis; CD54; CD95; HLA DR

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; FAS ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; MEMBRANE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BLAST CELL; CELL ADHESION; CELL DEATH; CONTROLLED STUDY; FETAL CALF SERUM; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN INDUCTION; RECEPTOR BINDING;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; BLAST CRISIS; BONE MARROW; CELL ADHESION; CHROMOSOME ABERRATIONS; FEMALE; HLA-DR ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-GAMMA, RECOMBINANT; KINETICS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029845847     PISSN: 13556568     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Hagenbeek A, Minimal residual disease in leukemia: state of the an. Leukemia (1991) 6(Suppl 2): 12-16.
2. List AR, Multiple drug resistance: clinical relevance in acute leukemia. Oncology (1993) 7: 23-8.
3. Oster W, Cicco NA, Klein H et al, Participation of the cytokines interleukin-6, tumor necrosis factor-a, and interleukin-1- secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J Clin Invest (1989) 84: 451-7.
4. Löwenberg B, van Putten WLJ, Touw IP et al, Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in acute myeloid leukemia. NEnglJMed(1993) 328: 614-9.
5. Munker R, Koeffler P, In vitro action of rumor necrosis factor on myeloid leukemia cells. Blood (1987) 69: 1102-08.
6. Beran M, McCredie MB, Keating MJ et al, Antileukemic effect of recombinant tumor necrosis factor a in vitro and its modulation by a and -y interferons. Blood (1988) 72: 728-38.
7. Hoang T, Levy B, Onetto N et al, Tumor necrosis factor a stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor. J Exp Med (\989~) 170: 15-26.
8. Yonehara S, Ishii A, Yonehara M, A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down-regulated with the receptor for tumor necrosis factor. J Exp Med (1989) 169: 1747-56.
9. Trauth BC, Klas C, Peters AMJ et al, Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (1989) 245: 301-05.
10. Owen-Schaub LB, Yonehara S, Grump WL et al, DNA fragmentation and cell death selectively triggered in activate human lymphocytes by Fas antigen engagement. Cell Immimol (1992) 140: 197-205.
11. Munker R, Lübbert M, Yonehara S et al, Expression of the Fas antigen on primary human leukemia cells. Aim Hematol (1995) 70: 15-17.
12. Nagata S, Golstein P, The Fas death factor. Science (1995) 267:1449-56.
13. Koeffler HP, Ranyard J, Yelton L, et al, -y-interferon induces expression of HLA-D antigens on normal and leukemic human myeloid cells. Proc NatlAcad Sei USA (1984) 81: 4080-4.
14. Gumina RJ, Freire-Moar J, de Young L et al, Transduction of the IFN-y signal for HLA-DR expression in the promonocytic cell line THP-1 involves a late-acting PKC activity. Cell Immnnol (1991) 138:265-79.
15. Dustin ML, Rothlein R, Bhan AK et al, Induction by IL-1 and IFN-: tissue-distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immnnol (1986) 137: 245-54.
16. Maio M, Del Vecchio LD, Expression and functional role of CD54/intercellular adhesion molecule-1 (ICAM-1) on human blood cells. Lenk Lymphoma (1992) 8: 23-33.
17. Möller P, Henne C, Leithäuser F et al, Coregulation of the Apo-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicular center and mediastinal B-cell lymphomas. Blood (1993) 81: 2067-75.
18. Leithäuser F, Dhein J, Mechtersheimer G et al, Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic ells. Lab Invest (1993) 69: 415-29.
19. Lozzio CB, Lozzio BB, Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood (1975) 45: 321-34.
20. Collins SJ, Gallo RC, Gallagher RE, Continuous growth and differentiation of human myelogenous leukemia cells in suspension culture. Nature (1977) 270: 347-9.
21. Koeffler P, Billing R, Lusis AJ et al, An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood (1980) 56: 265-73.
22. Andersson BS, Bergerheim USR, Collins VF et al, KBM-3, an in vitro model of human acute myelomonocytic leukemia. Exp Hematol (1992) 20: 361-7.
23. Andersson BS, Mroue M, Britten RA et al, Mechanisms of cyclophosphamide resistance in a human myeloid leukemia cell line. Acta Oncol (1995) 34:247-51.
24. Lanotte M, Martin-Thoruvenin V, Najman S et al, NB-4, a maturation-inducible cell line with t(15; 17) marker isolated from a human acute promyelocytic leukemia (M3). Blood (1991) 77: 1080-6.
25. Wang C, Koistinen P, Yang GS et al, Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia. Leukemia (1991) 5: 493-9.
26. Sundström C, Nilsson K, Establishment and characterization of a human histiocytic lymphoma cell line (U937). lut3 Cancer (1976) 17: 565-77.
27. Kitamura T, Tange T, Terasawa T et al, Establishment and characterization of a unique human cell line that proliferates dependently on GMCSF, IL-3, or erythropoietin. J Cell Physiol (1989) 140: 323-34.
28. Tsuchiya S, Yamabe M, Yamaguchi Y et al, Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer (1980) 26: 171-6.
29. Alderson MR, Tough TW, Davis-Smith T et al, Fas ligand mediates activation-induced death in human T lymphocytes. J fiep Med (1995) 181: 71-77.
30. Gorczyca W, Gong J, Darzynkiewicz Z, Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal transferase and nick translation assays. Cancer Res (1993) 53: 1945-51.
31. Itoh N, Yonehara S, Ishii A et al, The polypeptide encoded by the cDNA for human cell surface antigen Fas mediate apoptosis. Cell (1991) 66: 233-43.
32. Debatin KM, Krammer PH, Resistance to APO-1 (CD95) induced apoptosis in T-ALL is determined by a BCL-2 independent anti-apoptotic program. Leukemia (1995) 9: 815-20.
33. Notter W, Ludwig WD, Bremer S et al, Selective targeting of human lymphokine-activated killer cells by CD3 monoclonal antibody against the interferoninducible high-affinity Fey receptor (CD64) on autologous acute myeloid leukemic blast cells. Blood (1993) 82:3113-24.
34. Khoury E, Andre C, Pontzvert-Delucq S et ai, Tumor necrosis factor a (TNFα) downregulates c-kit proto-oncogene product expression in normal and acute myeloid leukemia CD34+ cells via p55 TNFα receptors. Blood (1994) 84: 2506-14.
35. Robertson MJ, Manley TJ, Pichert G et al, Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Lenk Lymphoma (1995) 17: 51-61.
36. + human marrow cells is induced by interferon γ and tumor necrosis factor a and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood (1995) 85: 3183-90.
37. Nagafuji K, Shibuya T, Harada M et al, Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood (1995) 86: 883-9.
38. Weller M, Frei K, Groscurth P et al, Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. J Clin Invest (1994) 94: 954-64.
39. Panayiotidis P, Ganeshaguru K, Foroni L et al, Expression and function of the FAS antigen in chronic lymphocytic leukemia and hairy cell leukemia. Leukemia (1995) 9: 1227-32.
40. Koeffler HP, Ranyard J, Yelton L et al, γ-IFN induces expression of HLA-D antigens on normal and leukemic human myeloid cells. Proc NatlAcadSci USA (1984) 81: 4080-4.
41. Huang YW, Burrows FJ, Vitetta ES, Cytotoxicity of a novel anti-ICAM-1 immunotoxin on human myeloma cell lines. Hybridoma (1993) 12: 661-75.
42. Suda T, Nagata S, Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med (1994) 179: 873-9.
43. Debatin KM, Goldmann CK, Waldmann TA et al, APO-1 induced apoptosis of leukemia cells from patients with ATL. Blood (1993) 81: 2972-7.
44. Owen-Schaub LB, Radinsky R, Kruzel E et al, AntiFas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res (1994) 54: 1580-6.
45. Shima Y, Nishimoto N, Ogata A et al, Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood (1995) 85: 757-64.
46. Itoh N, Tsujimoto Y, Nagata S, Effect of bcl-2 on Fas-antigen mediated cell death. J Immunol (1993) 151:621-7.
47. Sato T, Irie S, Kitada S et al, FAP-1; a protein tyrosine phosphatase that associates with Fas. Science (1995) 268:411-5.
48. Cheng J, Zhou T, Liu C et al, Protection from Fasmediated apoptosis by a soluble form of the Fas molecule. Science (1994) 263: 1759-62.